Unibail-Rodamco-Westfield (URW)
Euronext Paris · France · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 91.86 |
|---|---|
| 52-week range | 85.98 – 106.65 |
| Return, 1 month / 3 months | +0.2% / −12.7% |
| Return, 1 year / 3 years | +6.8% / +133.0% |
| Trend | Below its 200-day average |
| RSI (14) | 55 |
| Volatility (1 year) | 18.4% |
| Worst drawdown (1 year) | -18.8% |
| Average daily value traded | 27.65M EUR |
| Dividend yield | 4.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Unibail-Rodamco-Westfield is a commercial property company based in Paris that owns and operates shopping centres and retail destinations. Its portfolio includes large regional malls, many carrying the Westfield name, along with other retail and mixed-use properties in European cities and in the United States. The company leases space to retailers and consumer brands, and also manages and develops these destinations, serving shoppers and the communities around its centres.
On this site Unibail-Rodamco-Westfield appears as a stock on the Euronext Paris (France), code URW, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Unibail-Rodamco-Westfield (URW) trades on the Euronext Paris in France. It last closed at EUR 91.86 on 27 October 2026.
Its price-based Market X-Ray is 70 out of 100 (a fair price profile), ranking 105 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 6.8% and over the last three months it fell 12.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 62 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -4.8% | ||
| From 52-week high | -13.8% | ||
| Momentum | 54 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -12.7% | ||
| 6-month return | -6.9% | ||
| 12-month return, skipping the last month | 6.6% | ||
| Stability (higher is calmer) | 89 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 18.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.8% | ||
| Liquidity | 94 · Strong | Trades actively. | |
| Average daily value traded | 27.65M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 39 · Weak | Dividend is small or irregular. | |
| Dividend yield | 4.9% | ||
| Years with dividends | 3 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +3.6% |
|---|---|
| 1 month | +0.2% |
| 3 months | −12.7% |
| 6 months | −6.9% |
| 1 year | +6.8% |
| 3 years | +133.0% |
| 5 years | +53.1% |
Signals
| 50-day / 200-day average | 93.27 / 96.49 |
|---|---|
| Golden / death cross (60 days) | Death, 11 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.67 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 May 2026 | EUR 4.5000 |
| 8 May 2025 | EUR 3.5000 |
| 14 May 2024 | EUR 2.5000 |
| 24 Mar 2020 | EUR 5.4000 |
| 3 Jul 2019 | EUR 5.4000 |
| 27 Mar 2019 | EUR 5.4000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.